
Elisabeth Gustafsson, GU Ventures, is appointed Chairman of the Board and develops a strategic roadmap
Our company is currently transitioning into the commercialization phase and actively preparing for CE marking in accordance with MDR requirements. At present, Profundus employs a dedicated team of eleven professionals and is situated in the BioVentureHub, an esteemed innovation center hosted by AstraZeneca, located in Mölndal, Sweden. We are proud to have garnered financial support from both institutional and private investors.
The foundation of Profundus stems from a collaborative effort between four innovative researchers. Jörgen Thaung and Zoran Popovic, engineers with Master of Science degrees from Chalmers University of Technology and doctoral qualifications from the University of Gothenburg, recognized the need for an enhanced method of eye diagnostics during their research at the university’s ophthalmology department. They connected with Associate Professor Mette Owner-Petersen and PhD candidate Per Knutsson, who were part of a research group at the department of Astronomy and Astrophysics at Lund University who were working on multi-conjugate adaptive optics for ground-based telescope applications.
These four researchers leveraged their respective expertise, allowing the ophthalmology specialists to access unique knowledge while affording the astronomers the opportunity to witness the implementation of their technology first-hand. Together, they addressed a range of advanced technical challenges, culminating in the development of a patented method for advanced eye diagnostics.
Profundus will make a significant difference in retinal imaging diagnostics for the benefit of patients all around the world.
Profundus develops an innovative fundus camera and software system for identification of changes in retinal microstructures
– enabling early diagnosis, prevention and treatment.
B.Sc. in Mechanical Engineering, Registered Nurse
M.Sc. in Engineering Physics, Ph.D. in Vision Science in Ophthalmology, post doctorate and associate researcher
M.Sc. Electrical & Electronics Engineering Ph.D. Ophthalmology, physiological optics
M.Sc. in Chemical Engineering with Engineering Physics
B.Sc. Chemistry, Ph.D. in Analytical Pharmaceutical Chemistry
M.Sc. in Technical Physic
M.Sc. in Mechanical Engineering
Dipl.-Biol. (M.Sc. in Biology)
M.Sc. in Physics, Ph.D. in Photonics Engineering
Executive MBA & M.Sc. in Chemistry
M.Sc. in Business Administration
M.Sc. in Biotechnology
PhD
M.Sc. in Chem. Engineering
M.Sc. in Electrical & Electronics Engineering Ph.D. in Ophthalmology, physiological optics
M.Sc. in Chem. Engineering
Elisabeth Gustafsson, GU Ventures, is appointed Chairman of the Board and develops a strategic roadmap
Åsa Lindström is recruited as CEO of Profundus
Gobia Enterprises AB, Almi Invest, and Länsförsäkringar invest in Profundus
Profundus launches their new branding and logotype
The Founders Zoran Popovic and Jörgen Thaung join the company as employees
Profundus moves to AstraZeneca BioVentureHub in Mölndal, Sweden
CTO and first employee is recruited to Profundus
CE evaluation with regulatory consultants
New emission of shares
Contact taken with Notified Body, required for CE-marking process
Patent and IP strategy updated
Letter of interest from Rigshospitalet in Glostrup, Denmark
Matti Ahlqvist, Executive Director at AstraZeneca, is appointed as new Chairman of the Board.
University of Liverpool and Profundus AB sign Letter of Intent for camera delivery and academic partnership.
Profundus is one of 15 finalists from incubators and science parks throughout Europe in the 2024 Incubator Stars Challenge.
CEO Åsa Lindström presented Profundus in Stockholm Tech Arena.